UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study

Annals of oncology, 2022-05, Vol.33 (5), p.534-543

2022

Volltextzugriff (PDF)

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

The Lancet (British edition), 2015-10, Vol.386 (10001), p.1353-1361

2015

Volltextzugriff (PDF)

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer

Annals of oncology, 2013-03, Vol.24 (3), p.640-647

2013

Volltextzugriff (PDF)

Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial

BMC cancer, 2020-05, Vol.20 (1), p.392-392, Article 392

2020

Volltextzugriff (PDF)

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

Annals of oncology, 2014-02, Vol.25 (2), p.339-345

2014

Volltextzugriff (PDF)

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

Annals of oncology, 2015-02, Vol.26 (2), p.313-320

2015

Volltextzugriff (PDF)

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients

British journal of cancer, 2013-12, Vol.109 (12), p.2959-2964

2013

Volltextzugriff (PDF)

Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)

Annals of oncology, 2020-02, Vol.31 (2), p.228-235

2020

Volltextzugriff (PDF)

How I treat diffuse large B-cell lymphoma

ESMO open, 2023-02, Vol.8 (1), p.100750-100750, Article 100750

2023

Volltextzugriff (PDF)

Association between antibiotics use and outcome in patients with NSCLC treated with immunotherapeutics

Annals of oncology, 2019-04, Vol.30 (4), p.652-653

2019

Volltextzugriff (PDF)

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype

Annals of oncology, 2015-08, Vol.26 (8), p.1685-1691

2015

Volltextzugriff (PDF)

PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial

British journal of surgery, 2021-04, Vol.108 (3), p.308-314

2021

Volltextzugriff (PDF)

KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

Annals of oncology, 2018-10, Vol.29, p.viii729-viii729

2018

Volltextzugriff (PDF)

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial

British journal of cancer, 2015-04, Vol.112 (8), p.1405-1410

2015

Volltextzugriff (PDF)

Response to Rituximab after Failure of Cyclophosphamide in the Induction Treatment in a Patient with cANCA-associated Vasculitis and Pachymeningitis: a Case Report

Sovremennai͡a︡ revmatologii͡a, 2021-08, Vol.15 (4), p.68-71

2021

Volltextzugriff (PDF)

Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study

Leukemia, 2017-04, Vol.31 (4), p.997-1000

2017

Volltextzugriff (PDF)

Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin’s lymphoma: results from the randomized international GHSG HD18 trial

Annals of oncology, 2024-03, Vol.35 (3), p.276-284

2024

Volltextzugriff (PDF)

Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia

Oncogene, 2015-10, Vol.34 (42), p.5341-5351

2015

Volltextzugriff (PDF)

Successful cancer therapy: chance and challenges

Deutsche medizinische Wochenschrift (1946), 2013-10, Vol.138 (41), p.2083

2013

Volltextzugriff (PDF)

Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma

Annals of oncology, 2014-01, Vol.25 (1), p.171-176

2014

Volltextzugriff (PDF)

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial

British journal of cancer, 2013-08, Vol.109 (3), p.589-596

2013

Volltextzugriff (PDF)

Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients

Annals of oncology, 2019-01, Vol.30 (1), p.109-114

2019

Volltextzugriff (PDF)

P270 Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?

Breast (Edinburgh), 2023-04, Vol.68, p.S123-S124

2023

Volltextzugriff (PDF)

C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients

British journal of cancer, 2014-07, Vol.111 (1), p.55-60

2014

Volltextzugriff (PDF)

Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLL

Leukemia, 2011-09, Vol.25 (9), p.1452-1458

2011

Volltextzugriff (PDF)

1 – 25 von 963

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(904)
Mit Volltextzugriff
(829)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(435)
Life Sciences & Biomedicine
(388)
Humans
(359)
Female
(214)
Oncology
(178)
Male
(166)
Adult
(155)
Biological And Medical Sciences
(154)
Middle Aged
(154)
Medical Sciences
(145)
Aged
(130)
Hematology
(113)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(69)
Treatment Outcome
(65)
Adolescent
(64)
Aged, 80 And Over
(60)
Child
(58)
Hematologic And Hematopoietic Diseases
(56)
Pharmacology. Drug Treatments
(54)
Prognosis
(54)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer

Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients

Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)

How I treat diffuse large B-cell lymphoma

Association between antibiotics use and outcome in patients with NSCLC treated with immunotherapeutics

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype

PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial

KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial

Response to Rituximab after Failure of Cyclophosphamide in the Induction Treatment in a Patient with cANCA-associated Vasculitis and Pachymeningitis: a Case Report

Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study

Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin’s lymphoma: results from the randomized international GHSG HD18 trial

Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia

Successful cancer therapy: chance and challenges

Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial

Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients

P270 Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?

C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients

Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLL

Suchergebnisse filtern